| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 9.8 MB | Adobe PDF |
Orientador(es)
Resumo(s)
The expanding need for complex biologics for therapeutic applications, in‐vitro
pharmacology and toxicology studies and fundamental research demands the
production of banks of well‐characterized and safety‐tested stocks of a large
number of cell/tissue samples. This implies the development of effective
cryopreservation methodologies that can cope with process scalability and
automation and must reflect the biological and physical properties of the cells as
these can be significantly altered by the process.
